PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 10632359-1 1999 We previously found that 2-chloroethyl-3-sarcosin-amide-1-nitrosourea (SarCNU), a new chloroethylnitrosourea analogue presently in phase I clinical trials, is a selective cytotoxin that enters cells via the extraneuronal transporter for monoamine transmitters (EMT). 2-((((2-chloroethyl)nitrosoamino)carbonyl)amino)propanamide 25-69 IL2 inducible T cell kinase Homo sapiens 261-264 10632359-1 1999 We previously found that 2-chloroethyl-3-sarcosin-amide-1-nitrosourea (SarCNU), a new chloroethylnitrosourea analogue presently in phase I clinical trials, is a selective cytotoxin that enters cells via the extraneuronal transporter for monoamine transmitters (EMT). 2-((((2-chloroethyl)nitrosoamino)carbonyl)amino)propanamide 71-77 IL2 inducible T cell kinase Homo sapiens 261-264